A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma
Clinical trial NCT05506410 · RECRUITING
Trial details
- NCT number
- NCT05506410
- Sponsor
- Zhengzhou University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-12
- Primary completion
- 2024-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.